|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.02 MYR | 0.00% |
|
-4.09% | -15.44% |
| 05-04 | TA Securities Downgrades Fraser & Neave to Hold from Buy; Price Target is MYR33.60 | MT |
| 04-30 | Fraser & Neave posts quarterly profit attributable of 96.3 million RGT | RE |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.32 | 7.54 | 7.45 | 8.38 | 8.4 | |||||
Return on Total Capital | 10.45 | 9.55 | 9.35 | 10.47 | 10.49 | |||||
Return On Equity % | 14.34 | 13.17 | 17.11 | 15.69 | 13.79 | |||||
Return on Common Equity | 14.34 | 13.21 | 16.98 | 15.69 | 13.67 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 28.98 | 26.26 | 28.69 | 31.47 | 31.9 | |||||
SG&A Margin | 17.16 | 16.1 | 17.15 | 17.8 | 17.59 | |||||
EBITDA Margin % | 14.15 | 12.89 | 13.49 | 15.89 | 16.85 | |||||
EBITA Margin % | 11.52 | 10.56 | 11.16 | 13.6 | 14.42 | |||||
EBIT Margin % | 11.52 | 10.56 | 11.09 | 13.53 | 14.35 | |||||
Income From Continuing Operations Margin % | 9.57 | 8.55 | 10.84 | 10.38 | 9.9 | |||||
Net Income Margin % | 9.57 | 8.57 | 10.74 | 10.35 | 9.78 | |||||
Net Avail. For Common Margin % | 9.57 | 8.57 | 10.74 | 10.35 | 9.78 | |||||
Normalized Net Income Margin | 7.31 | 6.71 | 6.6 | 8.28 | 8.67 | |||||
Levered Free Cash Flow Margin | 8.61 | -4.27 | 14.48 | 6.65 | -6.6 | |||||
Unlevered Free Cash Flow Margin | 8.66 | -4.19 | 14.92 | 7.08 | -6.18 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.16 | 1.14 | 1.08 | 0.99 | 0.94 | |||||
Fixed Assets Turnover | 2.81 | 2.9 | 2.83 | 2.59 | 2.19 | |||||
Receivables Turnover (Average Receivables) | 8.57 | 9.53 | 8.36 | 8.41 | 8.26 | |||||
Inventory Turnover (Average Inventory) | 4.46 | 4.22 | 4.28 | 4.76 | 4.75 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.69 | 2.68 | 2.95 | 2.46 | 2.01 | |||||
Quick Ratio | 1.62 | 1.31 | 2.04 | 1.63 | 1.11 | |||||
Operating Cash Flow to Current Liabilities | 0.94 | 0.13 | 1.24 | 0.66 | 0.52 | |||||
Days Sales Outstanding (Average Receivables) | 42.59 | 38.31 | 43.68 | 43.5 | 44.21 | |||||
Days Outstanding Inventory (Average Inventory) | 81.85 | 86.44 | 85.23 | 76.83 | 76.79 | |||||
Average Days Payable Outstanding | 33.09 | 32.46 | 36.12 | 33.31 | 31.26 | |||||
Cash Conversion Cycle (Average Days) | 91.35 | 92.29 | 92.78 | 87.02 | 89.74 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 2.31 | 10.39 | 22.91 | 21.21 | 16.92 | |||||
Total Debt / Total Capital | 2.26 | 9.41 | 18.64 | 17.5 | 14.47 | |||||
LT Debt/Equity | 1.91 | 8.81 | 22.54 | 17.81 | 10.12 | |||||
Long-Term Debt / Total Capital | 1.87 | 7.98 | 18.34 | 14.7 | 8.65 | |||||
Total Liabilities / Total Assets | 22.39 | 28.78 | 34.43 | 34.48 | 30.9 | |||||
EBIT / Interest Expense | 154.5 | 85.23 | 15.73 | 19.92 | 21.43 | |||||
EBITDA / Interest Expense | 197.93 | 107.5 | 19.79 | 23.88 | 25.68 | |||||
(EBITDA - Capex) / Interest Expense | 150.79 | 71.8 | 16.79 | 16.64 | 4.5 | |||||
Total Debt / EBITDA | 0.11 | 0.52 | 1.1 | 0.89 | 0.73 | |||||
Net Debt / EBITDA | -0.81 | -0.26 | -0.4 | -0.45 | 0.02 | |||||
Total Debt / (EBITDA - Capex) | 0.14 | 0.78 | 1.3 | 1.28 | 4.2 | |||||
Net Debt / (EBITDA - Capex) | -1.06 | -0.39 | -0.47 | -0.65 | 0.11 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 3.57 | 8.21 | 11.88 | 4.88 | -0.93 | |||||
Gross Profit, 1 Yr. Growth % | -2.74 | -1.68 | 22.2 | 15.07 | 0.4 | |||||
EBITDA, 1 Yr. Growth % | -5.82 | -1.45 | 22.15 | 23.52 | 5.06 | |||||
EBITA, 1 Yr. Growth % | -7.74 | -0.8 | 24.44 | 27.84 | 5.05 | |||||
EBIT, 1 Yr. Growth % | -7.74 | -0.8 | 23.66 | 27.95 | 5.08 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -3.66 | -3.25 | 41.79 | 0.42 | -5.44 | |||||
Net Income, 1 Yr. Growth % | -3.71 | -3.03 | 40.11 | 1.09 | -6.32 | |||||
Normalized Net Income, 1 Yr. Growth % | -7.8 | -0.7 | 15.79 | 31.54 | 3.78 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -3.67 | -3.07 | 40.08 | 1.16 | -6.29 | |||||
Accounts Receivable, 1 Yr. Growth % | -4.32 | 25.92 | 9.63 | -0.78 | 2.7 | |||||
Inventory, 1 Yr. Growth % | 0.57 | 36.62 | -15.22 | -2.52 | -0.11 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.49 | 5.53 | 23.5 | 7.33 | 27.06 | |||||
Total Assets, 1 Yr. Growth % | 3.17 | 15.39 | 21.98 | 7.1 | 2.54 | |||||
Tangible Book Value, 1 Yr. Growth % | 3.25 | 5.86 | 0.67 | 8.11 | 9.34 | |||||
Common Equity, 1 Yr. Growth % | 4.77 | 5.8 | 12.09 | 6.96 | 8.03 | |||||
Cash From Operations, 1 Yr. Growth % | 80.12 | -82.66 | 884.03 | -30.42 | -17.56 | |||||
Capital Expenditures, 1 Yr. Growth % | -30 | 36.17 | -46.61 | 144.13 | 185.95 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 878.38 | -153.69 | -452 | -51.81 | -198.29 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 819.43 | -152.43 | -468.92 | -50.25 | -186.54 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 0 | 5 | 3.17 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.66 | 5.87 | 10.03 | 8.33 | 1.93 | |||||
Gross Profit, 2 Yr. CAGR % | -2.8 | -2.34 | 9.61 | 18.58 | 7.48 | |||||
EBITDA, 2 Yr. CAGR % | -2.97 | -3.66 | 7.45 | 22.84 | 13.92 | |||||
EBITA, 2 Yr. CAGR % | -4.41 | -4.33 | 8.29 | 26.13 | 15.88 | |||||
EBIT, 2 Yr. CAGR % | -4.41 | -4.33 | 7.95 | 25.79 | 15.95 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -1.86 | -3.46 | 17.12 | 19.33 | -2.56 | |||||
Net Income, 2 Yr. CAGR % | -1.86 | -3.37 | 16.56 | 19.01 | -2.68 | |||||
Normalized Net Income, 2 Yr. CAGR % | -4.84 | -4.32 | 4.55 | 23.41 | 16.84 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -1.81 | -3.37 | 16.52 | 19.04 | -2.64 | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.21 | 3.04 | 22.75 | 4.3 | 0.95 | |||||
Inventory, 2 Yr. CAGR % | 6.8 | 17.22 | 7.62 | -9.09 | -1.32 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 5.75 | 4.51 | 14.16 | 15.13 | 16.78 | |||||
Total Assets, 2 Yr. CAGR % | 1.81 | 9.11 | 18.64 | 14.3 | 4.8 | |||||
Tangible Book Value, 2 Yr. CAGR % | 6.47 | 4.55 | 3.23 | 4.32 | 8.72 | |||||
Common Equity, 2 Yr. CAGR % | 5.57 | 5.29 | 8.9 | 9.5 | 7.5 | |||||
Cash From Operations, 2 Yr. CAGR % | 3.3 | -44.11 | 30.63 | 161.67 | -24.26 | |||||
Capital Expenditures, 2 Yr. CAGR % | 2.68 | -2.37 | -14.74 | 14.17 | 164.21 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 1.15 | 129.19 | 42.68 | 30.25 | -31.17 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 1.04 | 119.56 | 44.45 | 35.48 | -34.38 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 0 | 0 | 2.47 | 4.08 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.19 | 3.12 | 7.83 | 8.29 | 5.15 | |||||
Gross Profit, 3 Yr. CAGR % | 1.35 | -2.51 | 5.24 | 11.4 | 12.18 | |||||
EBITDA, 3 Yr. CAGR % | 4.66 | -2.47 | 2.83 | 12.56 | 16.6 | |||||
EBITA, 3 Yr. CAGR % | 4.1 | -3.22 | 2.66 | 14.45 | 18.67 | |||||
EBIT, 3 Yr. CAGR % | 4.1 | -3.22 | 2.44 | 14.24 | 18.47 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 0.74 | -2.33 | 9.74 | 11.27 | 10.42 | |||||
Net Income, 3 Yr. CAGR % | 0.74 | -2.25 | 9.37 | 11.16 | 9.89 | |||||
Normalized Net Income, 3 Yr. CAGR % | 4.41 | -3.48 | 0.26 | 12.87 | 16.49 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 0.85 | -2.23 | 9.36 | 11.16 | 9.91 | |||||
Accounts Receivable, 3 Yr. CAGR % | -3.8 | 2 | 8.31 | 14.35 | 3.76 | |||||
Inventory, 3 Yr. CAGR % | 9.89 | 15.94 | 5.22 | 4.13 | -6.19 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 5.33 | 5.68 | 10.49 | 11.84 | 18.98 | |||||
Total Assets, 3 Yr. CAGR % | 2.78 | 6.15 | 13.24 | 14.66 | 10.24 | |||||
Tangible Book Value, 3 Yr. CAGR % | 7.74 | 6.27 | 3.24 | 4.83 | 5.97 | |||||
Common Equity, 3 Yr. CAGR % | 6.93 | 5.65 | 7.51 | 8.25 | 9.01 | |||||
Cash From Operations, 3 Yr. CAGR % | 3.98 | -43.02 | 45.39 | 5.89 | 78.05 | |||||
Capital Expenditures, 3 Yr. CAGR % | -7.12 | 12.81 | -20.16 | 21.07 | 55.04 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 15.72 | -18.1 | 171.07 | -0.63 | 18.58 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 14.35 | -18.81 | 167.7 | 1.26 | 16.68 | |||||
Dividend Per Share, 3 Yr. CAGR % | 1.43 | 0 | 0 | 1.64 | 2.7 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.18 | 1.74 | 5.26 | 5.17 | 5.43 | |||||
Gross Profit, 5 Yr. CAGR % | -4.23 | -3.06 | 4.53 | 5.43 | 6.13 | |||||
EBITDA, 5 Yr. CAGR % | 2.87 | 5.8 | 5.77 | 6.07 | 7.13 | |||||
EBITA, 5 Yr. CAGR % | 2.67 | 6.28 | 5.76 | 6.49 | 7.76 | |||||
EBIT, 5 Yr. CAGR % | 2.67 | 6.28 | 5.62 | 6.38 | 7.65 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 0.5 | 3.4 | 7 | 5.82 | 4.65 | |||||
Net Income, 5 Yr. CAGR % | 0.5 | 3.45 | 6.79 | 5.76 | 4.38 | |||||
Normalized Net Income, 5 Yr. CAGR % | 1.62 | 6.1 | 4.47 | 5.42 | 6.59 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 0.53 | 3.46 | 6.85 | 5.78 | 4.39 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.12 | 0.54 | 3.4 | 4.73 | 5.3 | |||||
Inventory, 5 Yr. CAGR % | 4.98 | 10.76 | 8.98 | 5.19 | 2.55 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.12 | 5.77 | 8.78 | 9.36 | 12.96 | |||||
Total Assets, 5 Yr. CAGR % | 2.53 | 5.34 | 8.85 | 9.34 | 9.78 | |||||
Tangible Book Value, 5 Yr. CAGR % | 7.94 | 7.53 | 5.92 | 5.48 | 5.4 | |||||
Common Equity, 5 Yr. CAGR % | 7.22 | 6.94 | 7.72 | 7.17 | 7.5 | |||||
Cash From Operations, 5 Yr. CAGR % | 4.79 | -13.42 | 13.92 | 4.85 | 12.01 | |||||
Capital Expenditures, 5 Yr. CAGR % | -0.61 | 4.94 | -10.25 | 13.35 | 28.86 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 12.96 | 33.56 | 25.83 | 0.08 | 56.66 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 12.06 | 39.58 | 25.55 | 1.17 | 52.55 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0.85 | 0.85 | 0.85 | 0.98 | 1.61 |
- Stock Market
- Equities
- F&N Stock
- Financials Fraser & Neave Holdings
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















